APA (7th ed.) Citation

Takeda, M. (2020). Editorial Comment to OnabotulinumtoxinA (botulinum toxin type A) for the treatment of Japanese patients with overactive bladder and urinary incontinence: Results of single‐dose treatment from a phase III, randomized, double‐blind, placebo‐controlled trial (interim analysis). International journal of urology, 27(3), 234-235. https://doi.org/10.1111/iju.14226

Chicago Style (17th ed.) Citation

Takeda, Masayuki. "Editorial Comment to OnabotulinumtoxinA (botulinum Toxin Type A) for the Treatment of Japanese Patients with Overactive Bladder and Urinary Incontinence: Results of Single‐dose Treatment from a Phase III, Randomized, Double‐blind, Placebo‐controlled Trial (interim Analysis)." International Journal of Urology 27, no. 3 (2020): 234-235. https://doi.org/10.1111/iju.14226.

MLA (9th ed.) Citation

Takeda, Masayuki. "Editorial Comment to OnabotulinumtoxinA (botulinum Toxin Type A) for the Treatment of Japanese Patients with Overactive Bladder and Urinary Incontinence: Results of Single‐dose Treatment from a Phase III, Randomized, Double‐blind, Placebo‐controlled Trial (interim Analysis)." International Journal of Urology, vol. 27, no. 3, 2020, pp. 234-235, https://doi.org/10.1111/iju.14226.